Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Packer

Showing results (601-610 of 706) with videos related to

Pageof 71
Sort By:
Neurology. Genetics|August 11, 2021
Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1Karin S Walsh, Pamela L Wolters, Brigitte C Widemann, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 2, 2015
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium studyLindsey M Hoffman, Maryam Fouladi, James Olson, et al.
Bioinformatics (Oxford, England)|February 6, 2023
DeepPheWAS: an R package for phenotype generation and association analysis for phenome-wide association studiesRichard J Packer, Alex T Williams, William Hennah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor controlR J Packer, J M Boyett, A J Janss, et al.
Cancer|August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumorsS M Blaney, P C Phillips, R J Packer, et al.
NPJ Precision Oncology|September 6, 2022
Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumorsErin R Bonner, Robin Harrington, Augustine Eze, et al.
Journal of Neurosurgery|April 3, 1998
Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer GroupP L Robertson, P M Zeltzer, J M Boyett, et al.
Journal of Neuro-Oncology|June 5, 2025
Psychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairmentsBelinda Barton, Pamela L Wolters, Karin S Walsh, et al.
Oncotarget|May 14, 2015
Proteomic profiling of high risk medulloblastoma reveals functional biologyJerome A Staal, Ling San Lau, Huizhen Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findingsLisa Diller, Eric J Chow, James G Gurney, et al.
Pageof 71

Showing results (601-610 of 706) with videos related to

Sort By:
Pageof 71
Neurology. Genetics|August 11, 2021
Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1Karin S Walsh, Pamela L Wolters, Brigitte C Widemann, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 2, 2015
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium studyLindsey M Hoffman, Maryam Fouladi, James Olson, et al.
Bioinformatics (Oxford, England)|February 6, 2023
DeepPheWAS: an R package for phenotype generation and association analysis for phenome-wide association studiesRichard J Packer, Alex T Williams, William Hennah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor controlR J Packer, J M Boyett, A J Janss, et al.
Cancer|August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumorsS M Blaney, P C Phillips, R J Packer, et al.
NPJ Precision Oncology|September 6, 2022
Circulating tumor DNA sequencing provides comprehensive mutation profiling for pediatric central nervous system tumorsErin R Bonner, Robin Harrington, Augustine Eze, et al.
Journal of Neurosurgery|April 3, 1998
Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer GroupP L Robertson, P M Zeltzer, J M Boyett, et al.
Journal of Neuro-Oncology|June 5, 2025
Psychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairmentsBelinda Barton, Pamela L Wolters, Karin S Walsh, et al.
Oncotarget|May 14, 2015
Proteomic profiling of high risk medulloblastoma reveals functional biologyJerome A Staal, Ling San Lau, Huizhen Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findingsLisa Diller, Eric J Chow, James G Gurney, et al.
Pageof 71